Clinical Outcomes in T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study
Clinical Colorectal Cancer · 2024
DOI: 10.1016/j.clcc.2024.04.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2024. Verfasst von Sarah Unrau und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Manitoba, Manitoba, Canada. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Neoplasm Recurrence, Local, Adenocarcinoma. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Manitoba, Manitoba, Canada.
- Cancer Research Institute, Himalayan Institute of Medical Sciences, Dehradun, India.
- CancerCare Manitoba, Manitoba, Canada.
- Université de Saint-Boniface, Manitoba, Canada.
- CancerCare Manitoba, Manitoba, Canada. Electronic address: maged.nashed@cancercare.mb.ca.
Zitieren
APA
Unrau, S., Barthwal, M., Gurram, L., Edward, M., Hurton, S., Kim, C., & Nashed, M. (2024). Clinical Outcomes in T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2024.04.005
Vancouver
Unrau S, Barthwal M, Gurram L, Edward M, Hurton S, Kim C, et al. Clinical Outcomes in T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study. Clinical Colorectal Cancer. 2024. doi:10.1016/j.clcc.2024.04.005
BibTeX
@article{Unrau2024,
author = {Unrau, Sarah and Barthwal, Mansi and Gurram, Lavanya and Edward, Mirette and Hurton, Scott and Kim, Christina and Nashed, Maged},
title = {Clinical Outcomes in T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study},
journal = {Clinical Colorectal Cancer},
year = {2024},
doi = {10.1016/j.clcc.2024.04.005}
}
EUVIMED